Wren Therapeutics' Corporate Minority Round

Wren Therapeutics raised a round of funding on January 17, 2017. Investors include Malin Corporation.

Wren Therapeutics is a biopharmaceutical company focusing on drug discovery and development for protein misfolding diseases, which include Alzheimer's and Parkinson's diseases, type-2 diabetes, and ma…

Articles about Wren Therapeutics' Corporate Minority Round: